Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

Steenholdt Casper; Al-khalaf Magid; Brynskov Jorn; Bendtzen Klaus; Thomsen Ole O.; Ainsworth Mark A.

首页> 外文期刊>Inflammatory bowel diseases >Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

【24h】

Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

机译：炎症性肠病患者抗英夫利昔单抗抗体水平变化的临床意义

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The aim of the study was to investigate variations in anti-infliximab (IFX) antibody (Ab) levels and clinical implications thereof in patients with inflammatory bowel disease (IBD).

机译：背景：该研究的目的是研究炎症性肠病（IBD）患者中抗英夫利昔单抗（IFX）抗体（Ab）水平的变化及其临床意义。

著录项

来源
《Inflammatory bowel diseases》 |2012年第12期|共9页
作者
Steenholdt Casper; Al-khalaf Magid; Brynskov Jorn; Bendtzen Klaus; Thomsen Ole O.; Ainsworth Mark A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
inflammatory bowel disease; Crohn's disease; ulcerative colitis; infliximab; TNF; antidrug antibody; anti-TNF antibodies; pharmacokinetics;

机译：炎症性肠病;克罗恩氏病;溃疡性结肠炎;英夫利昔单抗;TNF;抗药抗体;抗TNF抗体;药代动力学;

相似文献

外文文献
中文文献
专利

1. Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease [J] . Steenholdt Casper, Al-khalaf Magid, Brynskov Jorn, Inflammatory bowel diseases . 2012,第12期

机译：炎症性肠病患者抗英夫利昔单抗抗体水平变化的临床意义
2. Clinical relevance and inter-test reliability of anti-infliximab antibodies and infliximab trough levels in patients with inflammatory bowel disease [J] . Guiotto Cristina, Daperno Marco, Frigeri Francesco, Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver . 2016,第2期

机译：炎性肠病患者抗英夫利昔单抗抗体和英夫利昔单抗谷水平的临床相关性和测试间可靠性
3. Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease: Distinct Clinical Implications Revealed by a Novel Assay [J] . Weisshof Roni, Ungar Bella, Blatt Alexandra, Inflammatory bowel diseases . 2016,第7期

机译：炎症性肠病患者中和能力的抗嗜活增生抗体：新的测定揭示了不同的临床意义
4. Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases [C] . J.-F. COLOMBEL, M. TORUNE Falk Symposium . 2007

机译：炎症性肠病患者的发病率增加了与免疫调节治疗有关的发病危险
5. Clinical Outcomes in the Management of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease [D] . Manokaran, Krishanth. 2018

机译：炎症性肠病患者缺铁性贫血管理中的临床结果
6. Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease [O] . Renáta Bor, Klaudia Farkas, Anna Fábián, 2012

机译：炎性肠病患者血清英夫利昔单抗和抗英夫利昔单抗抗体水平测定的临床作用，最佳时机和频率
7. Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease [O] . Bor Renáta, Farkas Klaudia, Fábián Anna, 2017

机译：炎性肠病患者血清英夫利昔单抗和抗英夫利昔单抗抗体水平测定的临床作用，最佳时机和频率

Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

摘要

著录项

相似文献

相关主题

期刊订阅